Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Science
Read Me

Cidara Therapeutics and Melinta Therapeutics Announce FDA Approval of REZZAYO (Rezagungin for Injection) for the Treatment of Candidemia and Invasive Candidiasis
Read Me

Homology Medicines Announces Promotion of Julie Jordan, M.D., to Chief Medical Officer
Read Me

Rallybio Announces Proof-of-Concept Achieved for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
Read Me

Expansion Therapeutics Announces Key Additions and Updates to Scientific Advisory Board

Pushing the healthcare industry forward

$ 0 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $450M from 5AM Ventures VII and $300M from 5AM Opportunities II.
0

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
0

ONGOING CLINICAL TRIALS

Historically our portfolio companies have had over 80,000 patients enrolled across 8,000 test sites in clinical trials.

San Francisco, CA

Boston, MA

© 2023 5AM Venture Management LLC